Literature DB >> 21575874

Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." A Canadian perspective.

Serge Gauthier1, Christopher Patterson, Michael Gordon, Jean-Paul Soucy, François Schubert, Antoine Leuzy.   

Abstract

The criteria for mild cognitive impairment due to Alzheimer's disease (AD) and preclinical AD, while offering great hope of fostering research on primary and secondary prevention for AD, are currently unsuitable for use in general clinical practice and must be used with great caution in specialized memory clinics.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh：

Year:  2011        PMID： 21575874     DOI： 10.1016/j.jalz.2011.03.006

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN： 1552-5260            Impact factor:   21.566


  8 in total

Review 1.  Imaging markers for Alzheimer disease: which vs how.

Authors:  Giovanni B Frisoni; Martina Bocchetta; Gael Chételat; Gil D Rabinovici; Mony J de Leon; Jeffrey Kaye; Eric M Reiman; Philip Scheltens; Frederik Barkhof; Sandra E Black; David J Brooks; Maria C Carrillo; Nick C Fox; Karl Herholz; Agneta Nordberg; Clifford R Jack; William J Jagust; Keith A Johnson; Christopher C Rowe; Reisa A Sperling; William Thies; Lars-Olof Wahlund; Michael W Weiner; Patrizio Pasqualetti; Charles Decarli
Journal:  Neurology       Date:  2013-07-30       Impact factor: 9.910

2.  The earlier the better: Alzheimer's prevention, early detection, and the quest for pharmacological interventions.

Authors:  Annette Leibing
Journal:  Cult Med Psychiatry       Date:  2014-06

3.  Biomarker-based diagnosis of mild cognitive impairment due to Alzheimer's disease: how and what to tell. A kickstart to an ethical discussion.

Authors:  Corinna Porteri; Giovanni B Frisoni
Journal:  Front Aging Neurosci       Date:  2014-03-19       Impact factor: 5.750

4.  Neuropsychological Measures that Predict Progression from Mild Cognitive Impairment to Alzheimer's type dementia in Older Adults: a Systematic Review and Meta-Analysis.

Authors:  Sylvie Belleville; Céline Fouquet; Carol Hudon; Hervé Tchala Vignon Zomahoun; Jordie Croteau
Journal:  Neuropsychol Rev       Date:  2017-10-10       Impact factor: 7.444

5.  Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4).

Authors:  Serge Gauthier; Christopher Patterson; Howard Chertkow; Michael Gordon; Nathan Herrmann; Kenneth Rockwood; Pedro Rosa-Neto; Jean-Paul Soucy
Journal:  Can Geriatr J       Date:  2012-12-04

Review 6.  Identification of potential or preclinical cognitive impairment and the implications of sophisticated screening with biomarkers and cognitive testing: does it really matter?

Authors:  Michael Gordon
Journal:  Biomed Res Int       Date:  2013-07-08       Impact factor: 3.411

7.  The correlation of neuropsychological evaluation with 11C-PiB and 18F-FC119S amyloid PET in mild cognitive impairment and Alzheimer disease.

Authors:  Su Yeon Park; Byung Hyun Byun; Byung Il Kim; Sang Moo Lim; In Ok Ko; Kyo Chul Lee; Kyeong Min Kim; Yu Kyeong Kim; Jun-Young Lee; Seon Hee Bu; Jung Hwa Kim; Dae Yoon Chi; Jeong Ho Ha
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

8.  The Consortium for the early identification of Alzheimer's disease-Quebec (CIMA-Q).

Authors:  Sylvie Belleville; Andréa C LeBlanc; Marie-Jeanne Kergoat; Frédéric Calon; Pierrette Gaudreau; Sébastien S Hébert; Carol Hudon; Nicole Leclerc; Naguib Mechawar; Simon Duchesne; Serge Gauthier
Journal:  Alzheimers Dement (Amst)       Date:  2019-11-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.